Company · CIK 0001671502 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Quoin Pharmaceuticals, Ltd. · QNRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 PForm 4 → | Sep 1, 9:40 pm EDT | Denise P. CarterChief Operating Officer, Director | 20,490 | $4.88 | $99,991 | 37,709 | +119% | |
| Aug 31, 2026 PForm 4 → | Sep 1, 9:39 pm EDT | Michael MyersChief Executive Officer, Director | 20,490 | $4.88 | $99,991 | 37,713 | +119% | |
| Aug 31, 2026 PForm 4 → | Sep 1, 9:39 pm EDT | Sally Bridget LawlorChief Financial Officer | 10,244 | $4.88 | $49,991 | 10,684 | +2,328% | |
| Aug 31, 2026 PForm 4 → | Sep 1, 9:38 pm EDT | Anthony James CulverwellDirector | 6,146 | $4.88 | $29,992 | 40,364 | +18.0% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 PForm 4 → | Sep 1, 9:40 pm EDT | Denise P. CarterChief Operating Officer, Director | 10,245 | — | — | 10,245 | — | |
| Aug 31, 2026 PForm 4 → | Sep 1, 9:39 pm EDT | Michael MyersChief Executive Officer, Director | 10,245 | — | — | 10,245 | — | |
| Aug 31, 2026 PForm 4 → | Sep 1, 9:39 pm EDT | Sally Bridget LawlorChief Financial Officer | 5,122 | — | — | 5,122 | — | |
| Aug 31, 2026 PForm 4 → | Sep 1, 9:38 pm EDT | Anthony James CulverwellDirector | 3,073 | — | — | 3,073 | — |